BREO ELLIPTA 50-25 MCG INHALER

fluticasone furoate and vilanterol trifenatate
$6.4848per EA

Strength

50; 25 ug/1; ug/1

NDC

00173091610

Classification

Brand

Dosage Form

POWDER

Route

RESPIRATORY (INHALATION)

Last Updated

4/22/2026

Approval Type

New Drug (NDA)

FDA Application

NDA204275

On Market Since

5/12/2023

Pharmacological Classes

Adrenergic beta2-Agonists
Corticosteroid Hormone Receptor Agonists
Corticosteroid
beta2-Adrenergic Agonist

Price History

1W

0.0%

1M

+0.0%

3M

-0.0%

6M

-0.1%

1Y

-0.3%

3Y

N/A

5Y

N/A

All

-0.5%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.